Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors.
about
Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinomaSystemically administered liposome-encapsulated Ad-PEDF potentiates the anti-cancer effects in mouse lung metastasis melanomaE10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastasesAntitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.The current state of head and neck cancer gene therapy.VB-111 for cancer.Advances in image-guided intratumoral drug delivery techniques.Fighting Cancer with Mathematics and Viruses.Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Recent advances in oncolytic adenovirus therapies for cancer.Sustained local delivery of oncolytic short hairpin RNA adenoviruses for treatment of head and neck cancer.Gene delivery nanoparticles to modulate angiogenesis.Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.Therapeutic gene editing: delivery and regulatory perspectivesSuppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin.Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.
P2860
Q33724272-736D53F0-0391-4D11-B364-79BC4FE14279Q36799390-2EC24D3F-CAA3-4D79-B382-00A709D53B3FQ37335002-9F92F6C2-75FB-4616-9FE7-C8D8275D1077Q37370299-358FFD1F-50A3-46A3-90D5-8F08B88904F3Q37595513-35162F6E-AA5E-4B4D-AE42-BB6805FCFF30Q37941051-AE4D4992-3681-4654-B476-719DE82F1EADQ38027851-6A7FD1C8-B88E-455E-AE50-81FEE62851FAQ38612646-5563729D-DED1-459E-B09F-4F2D82A10149Q38674852-167CAE6F-F0D9-45B4-8054-9AD71834E527Q38769919-4ADCC66F-6136-432A-BD63-16F0986A1D3CQ38886593-C922270B-01EE-4725-90D0-51DB8C54A294Q38981481-4A03FEF6-783B-4185-9413-125F871223C0Q39027588-AA899DA8-A349-47E1-B74E-FF47B0D5FD57Q39178068-42D3EEAD-9755-437F-8BB2-7144F833F429Q39230418-B7ACEB58-003A-4B19-B1A0-3BB3F1BA6F9FQ39824366-BD964053-9CB7-4063-BF27-33839902ADD9Q50898463-5A42EDA2-C9FB-4898-BD0F-9B05C528E590
P2860
Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Pharmacokinetic and pharmacody ...... patients with advanced tumors.
@en
type
label
Pharmacokinetic and pharmacody ...... patients with advanced tumors.
@en
prefLabel
Pharmacokinetic and pharmacody ...... patients with advanced tumors.
@en
P2093
P2860
P356
P1433
P1476
Pharmacokinetic and pharmacody ...... patients with advanced tumors.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3303038
P577
2007-12-20T00:00:00Z
P5875
P6179
1013656087